• Skip to main content
  • Skip to header right navigation
  • Skip to after header navigation
  • Skip to site footer
  • Facebook
  • LinkedIn
  • Instagram
Logo Fondazione Ricerca e Innovazione CardiovascolareLogo Small - Fondazione RIC

Fondazione RIC

Uniti dalla fiducia per la ricerca

  • THE FOUNDATION
    • OUR STORY
    • GOVERNANCE & TEAM
    • SCIENTIFIC COMMITTEE
  • DCB ACADEMY
    • WHO WE ARE
    • LEADERSHIP
    • DCB ACADEMY: LESSONS
    • OUR SYMPOSIA
  • DEBS CONGRESS
    • DEBS CONGRESS 2026
    • DEBS CONGRESS 2027
  • OUR CLINICAL TRIALS
  • EDUCATIONAL EVENTS
  • JIM GISE ROMA
    • JIM GISE 2027
  • GET INVOLVED
  • PUBLICATIONS
    • ARTICLES
    • BOOKS
  • VIDEO
    • PRESS & INTERVIEWS
    • CONGRESSES
    • DCB ACADEMY SYMPOSIA
    • DCB ACADEMY LESSONS
  • PRESS
  • CONTACTS
Progetto: Gestione a distanza dello scompenso cardiaco

TRANSFORM II

Home » OUR CLINICAL TRIALS » TRANSFORM II

Study Chairman: Prof. Bernardo Cortese
Steering committee: Prof Bernardo Cortese, Prof Alexander Abizaid, Prof Fernando Alfonso, Prof Chema de la Torre Hernandez, Prof Stefano Rigattieri, Prof Antonio Greco
DSMB Coordinator: Prof Davide Capodanno
CEC Coordinator: Dr. Salvatore Brugaletta

TRANSFORM II is a multicenter, multinational, investigator-driven randomized clinical trial including centers from Europe, Asia, and South America and is comparing Magic Touch Sirolimus drug-coated balloon (DCB) to any everolimus-eluting stent in a broad spectrum of coronary artery disease (CAD) patients with native vessel disease diameters of 2–3.5 mm and lesion length up to 50 mm. This study is testing these 2 different revascularization strategies by assessing the non-inferiority of DCB as regards the primary endpoint of target lesion failure (TLF) and the superiority in terms of net adverse clinical events (NACE) at 1 year. Patients will be followed up clinically up to 5 years. The study has reached its primary endpoint and the results are expected to be presented in late 2026. This study has a DSMB coordinated by Prof Davide Capodanno, University of Catania, IT and a CEC coordinated by Dr Salvatore Brugaletta, Hospital Clínic in Barcelona, ES.

Will be presented as a late-breaking clinical trial at TCT 2026

Are you interested in participating in the study?

Submit your request

THE STUDY SITES AND CENTERS

Italy

Clinica San Carlo, Paderno Dugnano, Milan
PI: Guido Belli

Ospedale San Giuseppe Moscati, Aversa, CE
PI: Gianluca Caiazzo

ASST Grande Ospedale Metropolitano Niguarda, Milan
PI: Irene Bossi

Ospedale Civile Sant’Andrea, La Spezia
PI: Alberto Menozzi


Azienda Ospedaliero-Universitaria Sant’Andrea, Rome
PI: Stefano Rigattieri


Policlinico Tor Vergata, Rome

PI: Giuseppe Sangiorgi

Azienda Ospedaliera “Ospedali Riuniti Villa Sofia-Cervello” Palermo
PI: Elio Pieri

Ospedale Sandro Pertini, Rome
PI: Alessandro Sciahbasi

Ospedale S. Antonio Abate, Erice Casa Santa, Trapani
PI: Dario Buccheri

Fondazione Poliambulanza Brescia
PI: Diego Maffeo

Ospedale Policlinico San Martino, Genova
PI: Matteo Vercellino

IRCCS Ospedale Galeazzi – Sant’Ambrogio, Milan
PI: Alfonso Ielasi

A.R.N.A.S. Ospedali Civico Di Cristina Benfratelli Palermo
PI: Marco Caruso

Azienda Ospedaliera Universitaria Integrata Verona
PI: Flavio Ribichini

United Kingdom

University Hospitals Birmingham
PI: Sandeep Basavarajaiah

Golden Jubilee National Hospital
PI: Angie Ghattas

Altnagelvin Area Hospital
PI: Aaron Peace

St Bartholomew’s Hospital, W Smithfield, London EC1A 7BE, United Kingdom
PI: Daniel Jones

France

Clinique Louis Pasteur 7 Rue Parmentier, 54270 Essey-lès-Nancy, Francia
PI: Julien Lemoine

Groupe Hospitalier de La Rochelle
PI: Ludovic Meunier

Les Hôpitaux de Chartres, Hôpital Louis Pasteur, 4 Rue Claude Bernard 28630, Le Coudray, France
PI: Gregoire Range

Centre Hospitalier de Saint-Malo 1 Rue de la Marne, 35400 Saint-Malo, Francia
PI: Mourad Mejri

Hôpital Prive du Confluent, 4 Rue Éric Tabarly, 44000 Nantes, France
PI: Erwan Bressollette

Clinique Saint-Hilaire, 2 Pl. Saint-Hilaire, 76000 Rouen, France
PI: Matthieu Godin

Poland

1st Military Institute of Medicine, Aleje Racławickie 23, 20-049 Lublin
PI: Grzegorz Sobieszek

Heliodors Święcicki Clinical Univeristy Hospital, Ul. Stanislawa Przybyszewskiego 49, 60-355 Poznań
PI: Maciej Lesiak

Thailand

Ramathibodi Hospital, Mahidol University
PI: Mann Chandavimol

Spain

Hospital General Universitario de Ciudad Real (HGUCR), Ciudad Real
PI: Ignacio Sanchez-Perez

Hospital Universitario La Paz, Madrid
PI: Raul Moreno Gómez

Hospital Universitario Marqués de Valdecilla (HUMV), Santander
PI: Jose M De La Torre Hernandez

Hospital Universitario y Politécnico La Fe, Valencia
PI: Jorge Sanz Sánchez

Hospital Universitario de Txagorritxu, Vitoria-Gasteiz
PI: Merche Sanz Sanchez

Hospital de la Princesa, Madrid
PI: Fernando Alfonso

Lucus Augusti University Hospital, Lugo
PI: Carlos González Juanatey

Hospital Alvaro Cunqueiro-University Hospital of Vigo, Vigo
PI: Victor Alfonso Jiménez Díaz

Netherland

Albert Schweitzer Hospital, Dordrecht
PI: Oemrawsingh R.M

Erasmus University Medical Center, Rotterdam
PI: Roberto Diletti

Maasstad Hospital, RotterdamPI: Valeria Paradies

OLGV Onze Lieve Vrouwe Gasthuis location East, Amsterdam
PI: Vink M.A

Haga Hospital Els Borst-Eilersplein 275, Den Haag
PI: Samer Somi

Bangladesh

National Heart Foundation Hospital & Research Institute
PI: Fazila Malik

Bangladesh Specialized Hospital Ltd, Dhaka, Bangladesh
PI: Mir Jamal Uddin

Kurmitola General Hospital, Dhaka
PI: Mohsin Ahmed

National Institute of Cardiovascular Disease, Dhaka, Bangladesh
PI: Sayeedur Rahman Khan Rumi

LABAID Cardiac Hospital, Dhaka, Bangladesh
PI: Golam Azam

Malaysia

Hospital Queen Elizabeth II, Sabah
PI: Liew Houng Bang

University Malaya Medical Centre (Teaching and Research Hospital)
PI: Ahmad Syadi

Brunei

Jurong Park Medical Centre JPMC
PI: Paula Mota

Brazil

Institute Dante Pazzanese of Cardiology
PI: Ricardo Costa

INC (National Institute of Cardiology), Rio de Janeiro, RJ
PI: Cesar Medeiros

Hospital Santa Isabel R. Frei Cornélio, 200, Ubá- MG
PI: Ricardo Ghetti

InCor (Heart Institute)
PI: Carlo Campos

Hospital de Clínicas de Porto Alegre
PI: Marco Wainstein

INFORMATION

© Fondazione Ricerca e
Innovazione Cardiovascolare
Tax ID code
92567940157
Privacy – Cookie Policy –
Terms of Use

Follow us

  • Facebook
  • LinkedIn
  • Instagram
CONTACTS

Operational Headquarters:
Via Ettore Ponti 49 – Milan
Email: segreteria@fondazioneric.org
PEC: pecfondazioneric@legalmail.it


    Copyright © 2026 Fondazione Ricerca e Innovazione Cardiovascolare. All Rights Reserved.